DE68908414D1 - Pharmazeutische zusammensetzungen fuer die reizung eines immunostimulierenden effektes. - Google Patents

Pharmazeutische zusammensetzungen fuer die reizung eines immunostimulierenden effektes.

Info

Publication number
DE68908414D1
DE68908414D1 DE8989910909T DE68908414T DE68908414D1 DE 68908414 D1 DE68908414 D1 DE 68908414D1 DE 8989910909 T DE8989910909 T DE 8989910909T DE 68908414 T DE68908414 T DE 68908414T DE 68908414 D1 DE68908414 D1 DE 68908414D1
Authority
DE
Germany
Prior art keywords
irritation
pharmaceutical compositions
immunostimulating effect
immunostimulating
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989910909T
Other languages
English (en)
Other versions
DE68908414T2 (de
Inventor
Jack Melling
John Stephenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbiological Research Authority
Original Assignee
HEALTH LAB SERVICE BOARD
Public Health Laboratory Service Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEALTH LAB SERVICE BOARD, Public Health Laboratory Service Board filed Critical HEALTH LAB SERVICE BOARD
Application granted granted Critical
Publication of DE68908414D1 publication Critical patent/DE68908414D1/de
Publication of DE68908414T2 publication Critical patent/DE68908414T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE89910909T 1988-09-15 1989-09-14 Pharmazeutische zusammensetzungen für die reizung eines immunostimulierenden effektes. Expired - Fee Related DE68908414T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888821656A GB8821656D0 (en) 1988-09-15 1988-09-15 Pharmaceutical compositions for eliciting immunostimulant effect

Publications (2)

Publication Number Publication Date
DE68908414D1 true DE68908414D1 (de) 1993-09-16
DE68908414T2 DE68908414T2 (de) 1993-12-09

Family

ID=10643643

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89910909T Expired - Fee Related DE68908414T2 (de) 1988-09-15 1989-09-14 Pharmazeutische zusammensetzungen für die reizung eines immunostimulierenden effektes.

Country Status (8)

Country Link
EP (1) EP0434749B1 (de)
JP (1) JP3072489B2 (de)
AU (1) AU633851B2 (de)
CA (1) CA1337113C (de)
DE (1) DE68908414T2 (de)
GB (1) GB8821656D0 (de)
WO (1) WO1990002559A1 (de)
ZA (1) ZA897005B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9010058D0 (en) * 1990-05-04 1990-06-27 Health Lab Service Board Method and composition for the treatment of cancer
US5744139A (en) * 1991-06-28 1998-04-28 University Of Tennessee Research Corporation Insulin-like growth factor I (IGF-1) induced improvement of depressed T4/T8 ratios
AU2147192A (en) * 1991-06-28 1993-01-25 Genentech Inc. Method of stimulating immune response using growth hormone
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response
EP0952846A1 (de) * 1994-02-14 1999-11-03 Genzyme Corporation Prolactin als impfstoffadjuvans
DK1604685T3 (da) * 1997-08-28 2012-06-18 Cj Cheiljedang Corp Et svækket japansk encephalitisvirus
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371462A (en) * 1982-01-21 1983-02-01 Genex Corporation Method for purification of anterior pituitary hormones
JPS60214798A (ja) * 1984-04-06 1985-10-28 Kyowa Hakko Kogyo Co Ltd 魚類の成長ホルモン
AU5598286A (en) * 1985-04-10 1986-10-16 Unisearch Limited Method of using human growth hormone to stimulate the growth of agricultural animals
AU604820B2 (en) * 1988-01-08 1991-01-03 Chaovanee Dr. Aroonsakul Method of treatment of central nervous system diseases such as alzheimer's disease and parkinson's disease and method of diagnosing alzheimer's disease

Also Published As

Publication number Publication date
WO1990002559A1 (en) 1990-03-22
EP0434749B1 (de) 1993-08-11
GB8821656D0 (en) 1988-10-12
EP0434749A1 (de) 1991-07-03
AU633851B2 (en) 1993-02-11
CA1337113C (en) 1995-09-26
JP3072489B2 (ja) 2000-07-31
DE68908414T2 (de) 1993-12-09
AU4324389A (en) 1990-04-02
JPH04500675A (ja) 1992-02-06
ZA897005B (en) 1990-08-29

Similar Documents

Publication Publication Date Title
DE68906942D1 (de) Pharmazeutische zusammensetzungen fuer die parenterale anwendung.
DE69525148T2 (de) Pharmazeutische formulierung
DK481989D0 (da) Farmaceutiske formuleringer
FI934914A (fi) Farmaceutiska formuleringar
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
IT8821663A0 (it) Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A (fi) Farmaceutiska kompositioner.
DE69011885D1 (de) Auf die Mundschleimhaut aufbringbare Arzneizubereitung.
IT9048521A0 (it) Dispositivo di somministrazione.
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE69006094T2 (de) Pharmazeutische Zusammensetzungen.
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
DE68908414D1 (de) Pharmazeutische zusammensetzungen fuer die reizung eines immunostimulierenden effektes.
DK0511991T3 (da) Farmaceutisk formulering
IT8619382A0 (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
ATE92768T1 (de) Pharmazeutische zusammensetzungen fuer die reizung eines immunostimulierenden effektes.
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
DE69003003T2 (de) Pharmazeutische Zusammensetzung.
ATE90200T1 (de) Pharmazeutische zusammensetzungen fuer die parenterale anwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MICROBIOLOGICAL RESEARCH AUTHORITY, SALISBURY, GB

8339 Ceased/non-payment of the annual fee